New study aims to unlock genetic secrets of lung cancer spread
NCT ID NCT07630246
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at a specific type of lung cancer called lung adenocarcinoma and how it can spread through tiny air spaces in the lungs. Researchers will collect tumor and healthy tissue samples from 140 patients to find genetic markers that might predict this spread. The goal is to better understand the disease and improve future diagnosis and treatment options.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NMS Research | Cancer Nanomedicine - João Conde's Lab
Lisbon, Portugal
-
Unidade Local de Saúde de São José
Lisbon, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI be a Pathologist's second opinion?
- Blood tests could unlock early clues for three major lung diseases
- New biologic drug DBC-664 takes aim at Hard-to-Treat cancers
- Why some Never-Smokers get lung cancer: a new study investigates
- Could an asthma drug help fight lung cancer? early trial investigates
- Vaccine trains immune system to hunt down cancer cells